| Literature DB >> 15451224 |
Marie-Christine Chartier-Harlin1, Jennifer Kachergus, Christophe Roumier, Vincent Mouroux, Xavier Douay, Sarah Lincoln, Clotilde Levecque, Lydie Larvor, Joris Andrieux, Mary Hulihan, Nawal Waucquier, Luc Defebvre, Philippe Amouyel, Matthew Farrer, Alain Destée.
Abstract
Genomic triplication of the alpha-synuclein gene (SNCA) has been reported to cause hereditary early-onset parkinsonism with dementia. These findings prompted us to screen for multiplication of the SNCA locus in nine families in whom parkinsonism segregates as an autosomal dominant trait. One kindred was identified with SNCA duplication by semiquantitative PCR and confirmed by fluorescent in-situ hybridisation analysis in peripheral leucocytes. By contrast with SNCA triplication families, the clinical phenotype of SNCA duplication closely resembles idiopathic Parkinson's disease, which has a late age-of-onset, progresses slowly, and in which neither cognitive decline nor dementia are prominent. These findings suggest a direct relation between SNCA gene dosage and disease progression.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15451224 DOI: 10.1016/S0140-6736(04)17103-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321